$335.36
11.193.45%
At Close: -
$335.36
00.00%
After Hours: 4:05 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Molina Healthcare (NYSE:MOH) Stock, Analyst Ratings, Price Targets, Forecasts
Molina Healthcare Inc has a consensus price target of $366.68 based on the ratings of 25 analysts. The high is $439 issued by B of A Securities on April 1, 2024. The low is $296 issued by Morgan Stanley on August 31, 2021. The 3 most-recent analyst ratings were released by Stephens & Co., Cantor Fitzgerald, and TD Cowen on July 25, 2024, July 25, 2024, and July 24, 2024, respectively. With an average price target of $359 between Stephens & Co., Cantor Fitzgerald, and TD Cowen, there's an implied 7.05% upside for Molina Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
Cantor Fitzgerald
TD Cowen
Jefferies
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Molina Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/25/2024 | Buy Now | -4.58% | Stephens & Co. | Scott Fidel | $320 → $320 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/25/2024 | Buy Now | 21.06% | Cantor Fitzgerald | Sarah James | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2024 | Buy Now | 4.66% | TD Cowen | Gary Taylor | $412 → $351 | Maintains | Buy | Get Alert |
| 07/24/2024 | Buy Now | -11.44% | Jefferies | David Windley | $354 → $297 | Maintains | Hold | Get Alert |
| 07/23/2024 | Buy Now | 21.06% | Cantor Fitzgerald | Sarah James | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | -6.07% | Wells Fargo | Stephen Baxter | $375 → $315 | Maintains | Equal-Weight | Get Alert |
| 07/15/2024 | Buy Now | 19.27% | Truist Securities | David Macdonald | $440 → $400 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 17.78% | JP Morgan | Lisa Gill | $420 → $395 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 25.24% | JP Morgan | Lisa Gill | $435 → $420 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 20.77% | Baird | Michael Ha | → $405 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | Buy Now | 22.85% | TD Cowen | Gary Taylor | $453 → $412 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 11.82% | Wells Fargo | Stephen Baxter | $410 → $375 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 16.29% | Stephens & Co. | Scott Fidel | — | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 28.22% | Barclays | Andrew Mok | $437 → $430 | Maintains | Equal-Weight | Get Alert |
| 04/15/2024 | Buy Now | 22.26% | Wells Fargo | Stephen Baxter | $440 → $410 | Maintains | Equal-Weight | Get Alert |
| 04/04/2024 | Buy Now | 21.06% | Cantor Fitzgerald | Sarah James | → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 30.9% | B of A Securities | Kevin Fischbeck | → $439 | Downgrade | Neutral → Underperform | Get Alert |
| 03/28/2024 | Buy Now | 30.9% | B of A Securities | Kevin Fischbeck | → $439 | Downgrade | Neutral → Underperform | Get Alert |
| 03/20/2024 | Buy Now | 31.2% | Wells Fargo | Stephen Baxter | $420 → $440 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | 30.31% | Barclays | Andrew Mok | → $437 | Initiates | → Equal-Weight | Get Alert |
| 02/20/2024 | Buy Now | 37.17% | Truist Securities | David Macdonald | $435 → $460 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 25.24% | Wells Fargo | Stephen Baxter | $367 → $420 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 02/09/2024 | Buy Now | 21.06% | Cantor Fitzgerald | Sarah James | $374 → $406 | Maintains | Overweight | Get Alert |
| 12/21/2023 | Buy Now | 13.31% | UBS | Kevin Caliendo | $350 → $380 | Maintains | Neutral | Get Alert |
| 11/21/2023 | Buy Now | 11.52% | Cantor Fitzgerald | Sarah James | → $374 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 16.89% | JP Morgan | Calvin Sternick | $367 → $392 | Maintains | Overweight | Get Alert |
| 10/03/2023 | Buy Now | 4.37% | Stephens & Co. | Scott Fidel | → $350 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | 7.05% | Cantor Fitzgerald | Sarah James | → $359 | Reiterates | Overweight → Overweight | Get Alert |
| 07/14/2023 | Buy Now | 8.84% | Morgan Stanley | Ricky Goldwasser | $365 → $365 | Reiterates | Overweight → Overweight | Get Alert |
| 07/07/2023 | Buy Now | 1.68% | JP Morgan | Calvin Sternick | $348 → $341 | Maintains | Overweight | Get Alert |
| 06/20/2023 | Buy Now | 8.84% | Truist Securities | David Macdonald | $380 → $365 | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | -7.56% | UBS | Kevin Caliendo | → $310 | Initiates | → Neutral | Get Alert |
| 05/08/2023 | Buy Now | -0.11% | Deutsche Bank | George Hill | $365 → $335 | Maintains | Hold | Get Alert |
| 05/03/2023 | Buy Now | 4.07% | TD Cowen | Gary Taylor | $380 → $349 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | 8.84% | Deutsche Bank | George Hill | $356 → $365 | Maintains | Hold | Get Alert |
| 04/28/2023 | Buy Now | 4.37% | Credit Suisse | Jonathan Yong | $347 → $350 | Maintains | Outperform | Get Alert |
| 04/28/2023 | Buy Now | -13.53% | Wells Fargo | Stephen Baxter | $282 → $290 | Maintains | Underweight | Get Alert |
| 04/27/2023 | Buy Now | 4.37% | Stephens & Co. | Scott Fidel | → $350 | Reiterates | → Equal-Weight | Get Alert |
| 04/21/2023 | Buy Now | 5.56% | Cantor Fitzgerald | Sarah James | → $354 | Initiates | → Overweight | Get Alert |
| 03/21/2023 | Buy Now | -15.91% | Wells Fargo | Stephen Baxter | $307 → $282 | Maintains | Underweight | Get Alert |
| 02/23/2023 | Buy Now | 3.77% | JP Morgan | Calvin Sternick | $360 → $348 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | -8.46% | Wells Fargo | Stephen Baxter | $340 → $307 | Maintains | Underweight | Get Alert |
| 02/10/2023 | Buy Now | 13.31% | Truist Securities | David Macdonald | $400 → $380 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 3.47% | Credit Suisse | Jonathan Yong | $395 → $347 | Maintains | Outperform | Get Alert |
| 02/09/2023 | Buy Now | 11.82% | Stephens & Co. | Scott Fidel | → $375 | Maintains | Equal-Weight | Get Alert |
| 01/04/2023 | Buy Now | 11.82% | Barclays | Steve Valiquette | $400 → $375 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | 1.38% | Wells Fargo | Stephen Baxter | $345 → $340 | Maintains | Underweight | Get Alert |
| 12/13/2022 | Buy Now | 15.7% | B of A Securities | Kevin Fischbeck | → $388 | Upgrade | Underperform → Neutral | Get Alert |
| 11/01/2022 | Buy Now | 5.86% | Deutsche Bank | George Hill | $315 → $355 | Maintains | Hold | Get Alert |
| 10/28/2022 | Buy Now | 19.27% | Barclays | Steven Valiquette | $380 → $400 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 25.24% | Truist Securities | David Macdonald | $390 → $420 | Maintains | Buy | Get Alert |
| 10/27/2022 | Buy Now | 22.26% | Credit Suisse | A.J. Rice | $350 → $410 | Maintains | Outperform | Get Alert |
| 10/03/2022 | Buy Now | 7.35% | JP Morgan | Calvin Sternick | → $360 | Initiates | → Overweight | Get Alert |
| 08/26/2022 | Buy Now | 2.87% | Wells Fargo | Stephen Baxter | $307 → $345 | Maintains | Underweight | Get Alert |
| 07/29/2022 | Buy Now | 9.14% | Mizuho | Ann Hynes | $345 → $366 | Maintains | Buy | Get Alert |
| 07/29/2022 | Buy Now | 13.31% | Barclays | Steve Valiquette | $340 → $380 | Maintains | Overweight | Get Alert |
| 06/17/2022 | Buy Now | -7.56% | Loop Capital | Joseph France | → $310 | Initiates | → Hold | Get Alert |
| 05/26/2022 | Buy Now | -0.11% | B of A Securities | Kevin Fischbeck | $355 → $335 | Downgrade | Buy → Underperform | Get Alert |
| 05/25/2022 | Buy Now | -10.25% | Wells Fargo | Stephen Baxter | $308 → $301 | Maintains | Underweight | Get Alert |
| 05/02/2022 | Buy Now | -7.26% | Deutsche Bank | George Hill | $308 → $311 | Maintains | Hold | Get Alert |
| 02/22/2022 | Buy Now | 8.84% | Morgan Stanley | Ricky Goldwasser | $397 → $365 | Maintains | Overweight | Get Alert |
| 02/14/2022 | Buy Now | 13.31% | BMO Capital | Matt Borsch | $365 → $380 | Maintains | Outperform | Get Alert |
| 02/11/2022 | Buy Now | 2.87% | Mizuho | Ann Hynes | $330 → $345 | Maintains | Buy | Get Alert |
| 12/14/2021 | Buy Now | -0.11% | Goldman Sachs | Nathan Rich | — | Initiates | → Buy | Get Alert |
| 11/02/2021 | Buy Now | -16.21% | Wells Fargo | Stephen Baxter | — | Maintains | Underweight | Get Alert |
| 10/29/2021 | Buy Now | 18.38% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | Buy Now | -10.54% | Stephens & Co. | Scott Fidel | — | Maintains | Equal-Weight | Get Alert |
| 10/29/2021 | Buy Now | -1.6% | Credit Suisse | Jonathan Yong | — | Maintains | Outperform | Get Alert |
| 10/29/2021 | Buy Now | 1.38% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
| 09/20/2021 | Buy Now | -5.18% | Credit Suisse | — | — | Maintains | Outperform | Get Alert |
| 09/20/2021 | Buy Now | -1.6% | Truist Securities | David Macdonald | — | Maintains | Buy | Get Alert |
| 09/20/2021 | Buy Now | -16.51% | Stephens & Co. | Scott Fidel | — | Maintains | Equal-Weight | Get Alert |
| 09/20/2021 | Buy Now | -5.77% | Morgan Stanley | Ricky Goldwasser | — | Maintains | Overweight | Get Alert |
| 09/20/2021 | Buy Now | -9.05% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
| 08/31/2021 | Buy Now | -11.74% | Morgan Stanley | Craig Hettenbach | — | Maintains | Overweight | Get Alert |
| 08/03/2021 | Buy Now | -23.66% | Wells Fargo | Stephen Baxter | — | Maintains | Underweight | Get Alert |
| 07/30/2021 | Buy Now | -6.07% | BMO Capital | Matt Borsch | — | Maintains | Outperform | Get Alert |
| 07/30/2021 | Buy Now | -15.31% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Molina Healthcare (MOH) stock?
The latest price target for Molina Healthcare (NYSE:MOH) was reported by Stephens & Co. on July 25, 2024. The analyst firm set a price target for $320.00 expecting MOH to fall to within 12 months (a possible -4.58% downside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Molina Healthcare (MOH)?
The latest analyst rating for Molina Healthcare (NYSE:MOH) was provided by Stephens & Co., and Molina Healthcare reiterated their equal-weight rating.
When was the last upgrade for Molina Healthcare (MOH)?
The last upgrade for Molina Healthcare Inc happened on February 15, 2024 when Wells Fargo raised their price target to $420. Wells Fargo previously had an underweight for Molina Healthcare Inc.
When was the last downgrade for Molina Healthcare (MOH)?
The last downgrade for Molina Healthcare Inc happened on April 1, 2024 when B of A Securities changed their price target from N/A to $439 for Molina Healthcare Inc.
When is the next analyst rating going to be posted or updated for Molina Healthcare (MOH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Molina Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Molina Healthcare was filed on July 25, 2024 so you should expect the next rating to be made available sometime around July 25, 2025.
Is the Analyst Rating Molina Healthcare (MOH) correct?
While ratings are subjective and will change, the latest Molina Healthcare (MOH) rating was a reiterated with a price target of $320.00 to $320.00. The current price Molina Healthcare (MOH) is trading at is $335.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.